Patent ID: 8753605

Claim:
A method of detecting the over-expression of epidermal growth factor receptor (EGFR) in a subject, comprising: administering to the subject a 18 F-FBEM-CYS-Z EGFR:1907 probe, wherein 18 F-FBEM is N-2-(4- 18 F-fluorobenzamido)ethyl-maleimide), wherein Z EGFR:1907 is SEQ ID NO: 1, and CYS is cysteine; imaging at least a portion of the subject; and detecting the 18 F-FBEM-CYS-Z EGFR:1907 probe, wherein the location of the 18 F-FBEM-CYS-Z EGFR:1907 probe corresponds to the over-expression of the EGFR.